Amines & Plasticizers Ltd
Incorporated in 1973, Amines & Plasticizers Ltd manufactures over 60 different varieties of organic chemicals, amines, solvents, and
fertilizers. [1]
- Market Cap ₹ 817 Cr.
- Current Price ₹ 148
- High / Low ₹ 233 / 127
- Stock P/E 20.5
- Book Value ₹ 54.9
- Dividend Yield 0.34 %
- ROCE 16.9 %
- ROE 13.4 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 5.25% over past five years.
- Debtor days have increased from 70.6 to 86.1 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 300 | 260 | 295 | 326 | 455 | 399 | 442 | 563 | 593 | 645 | 656 | 571 | 597 | |
| Sales growth | +24% | -13% | +13% | +11% | +39% | -12% | +11% | +27% | +5% | +9% | +2% | -13% | -5% |
| 278 | 237 | 267 | 298 | 421 | 357 | 389 | 523 | 551 | 576 | 587 | 511 | 534 | |
| Operating Profit | 22 | 23 | 28 | 28 | 34 | 42 | 53 | 40 | 42 | 69 | 68 | 60 | 63 |
| OPM % | 7% | 9% | 10% | 9% | 7% | 10% | 12% | 7% | 7% | 11% | 10% | 10% | 11% |
| 1 | 1 | 2 | 5 | 3 | 1 | 5 | 5 | 1 | 2 | 1 | 1 | 1 | |
| Interest | 10 | 8 | 6 | 7 | 8 | 9 | 10 | 9 | 10 | 13 | 10 | 5 | 4 |
| Depreciation | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 6 |
| Profit before tax | 12 | 14 | 22 | 24 | 27 | 31 | 44 | 32 | 28 | 53 | 54 | 49 | 54 |
| Tax % | 33% | 32% | 29% | 35% | 35% | 19% | 26% | 26% | 26% | 26% | 26% | 26% | |
| 8 | 10 | 15 | 15 | 17 | 25 | 33 | 24 | 21 | 39 | 40 | 36 | 40 | |
| EPS in Rs | 1.40 | 1.78 | 2.81 | 2.81 | 3.14 | 4.50 | 5.95 | 4.32 | 3.79 | 7.14 | 7.25 | 6.63 | 7.26 |
| Dividend Payout % | 7% | 11% | 11% | 11% | 10% | 7% | 7% | 9% | 13% | 7% | 7% | 8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 5% |
| 3 Years: | -1% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 2% |
| 3 Years: | 20% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 5% |
| 3 Years: | -2% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 16% |
| 3 Years: | 16% |
| Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 34 | 37 | 49 | 62 | 77 | 97 | 130 | 152 | 170 | 207 | 244 | 277 | 291 |
| 56 | 53 | 52 | 45 | 67 | 58 | 74 | 72 | 85 | 85 | 77 | 27 | 22 | |
| 41 | 39 | 46 | 67 | 88 | 65 | 91 | 75 | 74 | 83 | 68 | 92 | 95 | |
| Total Liabilities | 137 | 140 | 157 | 185 | 244 | 232 | 306 | 310 | 340 | 386 | 400 | 407 | 419 |
| 30 | 29 | 36 | 40 | 43 | 75 | 73 | 84 | 80 | 80 | 80 | 76 | 74 | |
| CWIP | 0 | 0 | 1 | 1 | 11 | 3 | 11 | 3 | 5 | 3 | 0 | 0 | 0 |
| Investments | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 |
| 105 | 109 | 120 | 144 | 189 | 154 | 221 | 223 | 254 | 302 | 317 | 330 | 344 | |
| Total Assets | 137 | 140 | 157 | 185 | 244 | 232 | 306 | 310 | 340 | 386 | 400 | 407 | 419 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 12 | 11 | 21 | 9 | 37 | 44 | -28 | 3 | 47 | 24 | 64 | |
| -2 | -0 | -3 | -1 | -13 | -23 | -6 | -4 | -2 | -1 | -3 | -0 | |
| -2 | -12 | -8 | -16 | 10 | -23 | 6 | -13 | 1 | -15 | -20 | -58 | |
| Net Cash Flow | 0 | -0 | 0 | 4 | 5 | -8 | 44 | -44 | 1 | 30 | 1 | 5 |
| Free Cash Flow | 1 | 11 | 6 | 15 | -7 | 10 | 33 | -36 | 0 | 44 | 21 | 63 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 26% | 67% | 62% | 99% | 49% | 107% | 103% | -50% | 21% | 87% | 55% | 126% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 48 | 54 | 55 | 49 | 62 | 63 | 73 | 66 | 75 | 56 | 69 | 86 |
| Inventory Days | 61 | 63 | 76 | 98 | 65 | 84 | 73 | 81 | 66 | 76 | 72 | 83 |
| Days Payable | 56 | 61 | 72 | 92 | 83 | 76 | 100 | 56 | 52 | 57 | 45 | 61 |
| Cash Conversion Cycle | 54 | 57 | 60 | 55 | 43 | 71 | 47 | 91 | 90 | 75 | 96 | 108 |
| Working Capital Days | 26 | 33 | 32 | 35 | 27 | 51 | 32 | 65 | 72 | 71 | 85 | 118 |
| ROCE % | 24% | 22% | 27% | 27% | 25% | 26% | 28% | 18% | 15% | 23% | 20% | 17% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Export Revenue Share % |
|
||||||||||
| Alkanolamines / Ethanolamines Revenue Share % |
|||||||||||
| R&D Spend INR Crore |
|||||||||||
| Morpholine & Derivatives Revenue Share % |
|||||||||||
| Number of Countries Served countries |
|||||||||||
| Domestic Market Share in Ethanolamines / Alkanolamines % |
|||||||||||
| EO/PO Derivative Products Revenue Share % |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Amines & Plasticizers reported Q2FY27 revenue of ₹149.84 crore and PAT of ₹8.33 crore.
-
Intimation Of Withholding Of Final Dividend On Equity Shares Of The Company For The Financial Year 2025-26 Due To Non-Updation Of KYC.
- Final dividend for FY2025-26 withheld for non-KYC compliant shareholders until details are updated.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Submission of Newspaper publication in connection with Unaudited (Standalone & Consolidated) Financial Results for the Quarter and Half year ended September 30, 2026.
-
Submission Of Circular Sent To The Members Of The Company Inviting Unsecured Deposits In Form DPT-1, Along With The Statutory Auditors Certificate, Deposit Scheme And Application Form
- Company issued DPT-1 circular on November 4, 2026, inviting ₹2,500 lakh unsecured deposits from members.
- Unaudited (Standalone And Consolidated) Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026 ('The Results') Along With The Limited Review Report Thereon Issued By The Statutory Auditors Of The Company.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1]
APL was initially formed to take over India Carbons Ltd.’s project for manufacturing 3,000 tonnes of DOP plasticizers used in PVC applications. Over time, it evolved into a manufacturer and trader of organic and inorganic chemicals, including ethanolamines, morpholine, plasticizers, alkyl morpholine, gas treating solvents (like methyl diethanolamine), and morpholine oxide. Today, APL is a global supplier serving a wide range of industries.